Gemigliptin L-tartrate sesquihydrate
Gemigliptin L-tartrate sesquihydrate market is segmented by Type and by Application. Players, sta ... Read More
Global Valsartan Market Insights, Forecast to 2031
1 Study Coverage
1.1 Valsartan Product Introduction
1.2 Market by Type
1.2.1 Global Valsartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Market by Application
1.3.1 Global Valsartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Valsartan Sales Estimates and Forecasts 2017-2028
2.2 Global Valsartan Revenue Estimates and Forecasts 2017-2028
2.3 Global Valsartan Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Valsartan Sales by Region
2.4.1 Global Valsartan Sales by Region (2017-2022)
2.4.2 Global Sales Valsartan by Region (2023-2028)
2.5 Global Valsartan Revenue by Region
2.5.1 Global Valsartan Revenue by Region (2017-2022)
2.5.2 Global Valsartan Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Valsartan Sales by Manufacturers
3.1.1 Global Top Valsartan Manufacturers by Sales (2017-2022)
3.1.2 Global Valsartan Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Valsartan in 2021
3.2 Global Valsartan Revenue by Manufacturers
3.2.1 Global Valsartan Revenue by Manufacturers (2017-2022)
3.2.2 Global Valsartan Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Valsartan Revenue in 2021
3.3 Global Valsartan Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Valsartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Valsartan Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valsartan Sales by Type
4.1.1 Global Valsartan Historical Sales by Type (2017-2022)
4.1.2 Global Valsartan Forecasted Sales by Type (2023-2028)
4.1.3 Global Valsartan Sales Market Share by Type (2017-2028)
4.2 Global Valsartan Revenue by Type
4.2.1 Global Valsartan Historical Revenue by Type (2017-2022)
4.2.2 Global Valsartan Forecasted Revenue by Type (2023-2028)
4.2.3 Global Valsartan Revenue Market Share by Type (2017-2028)
4.3 Global Valsartan Price by Type
4.3.1 Global Valsartan Price by Type (2017-2022)
4.3.2 Global Valsartan Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Valsartan Sales by Application
5.1.1 Global Valsartan Historical Sales by Application (2017-2022)
5.1.2 Global Valsartan Forecasted Sales by Application (2023-2028)
5.1.3 Global Valsartan Sales Market Share by Application (2017-2028)
5.2 Global Valsartan Revenue by Application
5.2.1 Global Valsartan Historical Revenue by Application (2017-2022)
5.2.2 Global Valsartan Forecasted Revenue by Application (2023-2028)
5.2.3 Global Valsartan Revenue Market Share by Application (2017-2028)
5.3 Global Valsartan Price by Application
5.3.1 Global Valsartan Price by Application (2017-2022)
5.3.2 Global Valsartan Price Forecast by Application (2023-2028)
6 North America
6.1 North America Valsartan Market Size by Type
6.1.1 North America Valsartan Sales by Type (2017-2028)
6.1.2 North America Valsartan Revenue by Type (2017-2028)
6.2 North America Valsartan Market Size by Application
6.2.1 North America Valsartan Sales by Application (2017-2028)
6.2.2 North America Valsartan Revenue by Application (2017-2028)
6.3 North America Valsartan Market Size by Country
6.3.1 North America Valsartan Sales by Country (2017-2028)
6.3.2 North America Valsartan Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Valsartan Market Size by Type
7.1.1 Europe Valsartan Sales by Type (2017-2028)
7.1.2 Europe Valsartan Revenue by Type (2017-2028)
7.2 Europe Valsartan Market Size by Application
7.2.1 Europe Valsartan Sales by Application (2017-2028)
7.2.2 Europe Valsartan Revenue by Application (2017-2028)
7.3 Europe Valsartan Market Size by Country
7.3.1 Europe Valsartan Sales by Country (2017-2028)
7.3.2 Europe Valsartan Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Valsartan Market Size by Type
8.1.1 Asia Pacific Valsartan Sales by Type (2017-2028)
8.1.2 Asia Pacific Valsartan Revenue by Type (2017-2028)
8.2 Asia Pacific Valsartan Market Size by Application
8.2.1 Asia Pacific Valsartan Sales by Application (2017-2028)
8.2.2 Asia Pacific Valsartan Revenue by Application (2017-2028)
8.3 Asia Pacific Valsartan Market Size by Region
8.3.1 Asia Pacific Valsartan Sales by Region (2017-2028)
8.3.2 Asia Pacific Valsartan Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Valsartan Market Size by Type
9.1.1 Latin America Valsartan Sales by Type (2017-2028)
9.1.2 Latin America Valsartan Revenue by Type (2017-2028)
9.2 Latin America Valsartan Market Size by Application
9.2.1 Latin America Valsartan Sales by Application (2017-2028)
9.2.2 Latin America Valsartan Revenue by Application (2017-2028)
9.3 Latin America Valsartan Market Size by Country
9.3.1 Latin America Valsartan Sales by Country (2017-2028)
9.3.2 Latin America Valsartan Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Valsartan Market Size by Type
10.1.1 Middle East and Africa Valsartan Sales by Type (2017-2028)
10.1.2 Middle East and Africa Valsartan Revenue by Type (2017-2028)
10.2 Middle East and Africa Valsartan Market Size by Application
10.2.1 Middle East and Africa Valsartan Sales by Application (2017-2028)
10.2.2 Middle East and Africa Valsartan Revenue by Application (2017-2028)
10.3 Middle East and Africa Valsartan Market Size by Country
10.3.1 Middle East and Africa Valsartan Sales by Country (2017-2028)
10.3.2 Middle East and Africa Valsartan Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Corporation Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sun Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Overview
11.3.3 Teva Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Alembic Pharmaceuticals
11.5.1 Alembic Pharmaceuticals Corporation Information
11.5.2 Alembic Pharmaceuticals Overview
11.5.3 Alembic Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Alembic Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Alembic Pharmaceuticals Recent Developments
11.6 Lupin
11.6.1 Lupin Corporation Information
11.6.2 Lupin Overview
11.6.3 Lupin Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lupin Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lupin Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Corporation Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aurobindo Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurobindo Pharma Recent Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Corporation Information
11.8.2 Macleods Pharmaceuticals Overview
11.8.3 Macleods Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Macleods Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Macleods Pharmaceuticals Recent Developments
11.9 HETERO
11.9.1 HETERO Corporation Information
11.9.2 HETERO Overview
11.9.3 HETERO Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 HETERO Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 HETERO Recent Developments
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Corporation Information
11.10.2 Torrent Pharmaceuticals Overview
11.10.3 Torrent Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Torrent Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Torrent Pharmaceuticals Recent Developments
11.11 Huaren Pharmaceutical
11.11.1 Huaren Pharmaceutical Corporation Information
11.11.2 Huaren Pharmaceutical Overview
11.11.3 Huaren Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Huaren Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Huaren Pharmaceutical Recent Developments
11.12 Jubilant Pharma
11.12.1 Jubilant Pharma Corporation Information
11.12.2 Jubilant Pharma Overview
11.12.3 Jubilant Pharma Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Jubilant Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jubilant Pharma Recent Developments
11.13 Amneal Pharmaceuticals
11.13.1 Amneal Pharmaceuticals Corporation Information
11.13.2 Amneal Pharmaceuticals Overview
11.13.3 Amneal Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Amneal Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Amneal Pharmaceuticals Recent Developments
11.14 Zhejiang Huahai Pharmaceutical
11.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.14.2 Zhejiang Huahai Pharmaceutical Overview
11.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Zhejiang Huahai Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.15 Square Pharmaceuticals
11.15.1 Square Pharmaceuticals Corporation Information
11.15.2 Square Pharmaceuticals Overview
11.15.3 Square Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Square Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Square Pharmaceuticals Recent Developments
11.16 Unichem Laboratories
11.16.1 Unichem Laboratories Corporation Information
11.16.2 Unichem Laboratories Overview
11.16.3 Unichem Laboratories Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Unichem Laboratories Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Unichem Laboratories Recent Developments
11.17 LG Life Sciences
11.17.1 LG Life Sciences Corporation Information
11.17.2 LG Life Sciences Overview
11.17.3 LG Life Sciences Valsartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 LG Life Sciences Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 LG Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Valsartan Industry Chain Analysis
12.2 Valsartan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valsartan Production Mode & Process
12.4 Valsartan Sales and Marketing
12.4.1 Valsartan Sales Channels
12.4.2 Valsartan Distributors
12.5 Valsartan Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Valsartan Industry Trends
13.2 Valsartan Market Drivers
13.3 Valsartan Market Challenges
13.4 Valsartan Market Restraints
14 Key Findings in The Global Valsartan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Valsartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 40 mg Tablets
Table 3. Major Manufacturers of 80 mg Tablets
Table 4. Major Manufacturers of 160 mg Tablets
Table 5. Major Manufacturers of 320 mg Tablets
Table 6. Global Valsartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Valsartan Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Valsartan Sales by Region (2017-2022) & (K Units)
Table 9. Global Valsartan Sales Market Share by Region (2017-2022)
Table 10. Global Valsartan Sales by Region (2023-2028) & (K Units)
Table 11. Global Valsartan Sales Market Share by Region (2023-2028)
Table 12. Global Valsartan Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Valsartan Revenue Market Share by Region (2017-2022)
Table 14. Global Valsartan Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Valsartan Revenue Market Share by Region (2023-2028)
Table 16. Global Valsartan Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Valsartan Sales Share by Manufacturers (2017-2022)
Table 18. Global Valsartan Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Valsartan Revenue Share by Manufacturers (2017-2022)
Table 20. Valsartan Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Valsartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Valsartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan as of 2021)
Table 23. Valsartan Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Valsartan Product Offered
Table 25. Date of Manufacturers Enter into Valsartan Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Valsartan Sales by Type (2017-2022) & (K Units)
Table 28. Global Valsartan Sales by Type (2023-2028) & (K Units)
Table 29. Global Valsartan Sales Share by Type (2017-2022)
Table 30. Global Valsartan Sales Share by Type (2023-2028)
Table 31. Global Valsartan Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Valsartan Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Valsartan Revenue Share by Type (2017-2022)
Table 34. Global Valsartan Revenue Share by Type (2023-2028)
Table 35. Valsartan Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Valsartan Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Valsartan Sales by Application (2017-2022) & (K Units)
Table 38. Global Valsartan Sales by Application (2023-2028) & (K Units)
Table 39. Global Valsartan Sales Share by Application (2017-2022)
Table 40. Global Valsartan Sales Share by Application (2023-2028)
Table 41. Global Valsartan Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Valsartan Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Valsartan Revenue Share by Application (2017-2022)
Table 44. Global Valsartan Revenue Share by Application (2023-2028)
Table 45. Valsartan Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Valsartan Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Valsartan Sales by Type (2017-2022) & (K Units)
Table 48. North America Valsartan Sales by Type (2023-2028) & (K Units)
Table 49. North America Valsartan Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Valsartan Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Valsartan Sales by Application (2017-2022) & (K Units)
Table 52. North America Valsartan Sales by Application (2023-2028) & (K Units)
Table 53. North America Valsartan Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Valsartan Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Valsartan Sales by Country (2017-2022) & (K Units)
Table 56. North America Valsartan Sales by Country (2023-2028) & (K Units)
Table 57. North America Valsartan Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Valsartan Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Valsartan Sales by Type (2017-2022) & (K Units)
Table 60. Europe Valsartan Sales by Type (2023-2028) & (K Units)
Table 61. Europe Valsartan Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Valsartan Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Valsartan Sales by Application (2017-2022) & (K Units)
Table 64. Europe Valsartan Sales by Application (2023-2028) & (K Units)
Table 65. Europe Valsartan Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Valsartan Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Valsartan Sales by Country (2017-2022) & (K Units)
Table 68. Europe Valsartan Sales by Country (2023-2028) & (K Units)
Table 69. Europe Valsartan Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Valsartan Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Valsartan Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Valsartan Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Valsartan Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Valsartan Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Valsartan Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Valsartan Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Valsartan Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Valsartan Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Valsartan Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Valsartan Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Valsartan Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Valsartan Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Valsartan Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Valsartan Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Valsartan Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Valsartan Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Valsartan Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Valsartan Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Valsartan Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Valsartan Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Valsartan Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Valsartan Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Valsartan Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Valsartan Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Valsartan Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Valsartan Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Valsartan Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Valsartan Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Valsartan Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Valsartan Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Valsartan Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Valsartan Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Valsartan Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Valsartan Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Valsartan Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Valsartan Revenue by Country (2023-2028) & (US$ Million)
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Novartis Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novartis Recent Developments
Table 112. Sun Pharmaceutical Corporation Information
Table 113. Sun Pharmaceutical Description and Major Businesses
Table 114. Sun Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Sun Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sun Pharmaceutical Recent Developments
Table 117. Teva Corporation Information
Table 118. Teva Description and Major Businesses
Table 119. Teva Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Teva Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Recent Developments
Table 122. Mylan Corporation Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Mylan Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Recent Developments
Table 127. Alembic Pharmaceuticals Corporation Information
Table 128. Alembic Pharmaceuticals Description and Major Businesses
Table 129. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Alembic Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Alembic Pharmaceuticals Recent Developments
Table 132. Lupin Corporation Information
Table 133. Lupin Description and Major Businesses
Table 134. Lupin Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Lupin Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Lupin Recent Developments
Table 137. Aurobindo Pharma Corporation Information
Table 138. Aurobindo Pharma Description and Major Businesses
Table 139. Aurobindo Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Aurobindo Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Aurobindo Pharma Recent Developments
Table 142. Macleods Pharmaceuticals Corporation Information
Table 143. Macleods Pharmaceuticals Description and Major Businesses
Table 144. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Macleods Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Macleods Pharmaceuticals Recent Developments
Table 147. HETERO Corporation Information
Table 148. HETERO Description and Major Businesses
Table 149. HETERO Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. HETERO Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. HETERO Recent Developments
Table 152. Torrent Pharmaceuticals Corporation Information
Table 153. Torrent Pharmaceuticals Description and Major Businesses
Table 154. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Torrent Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Torrent Pharmaceuticals Recent Developments
Table 157. Huaren Pharmaceutical Corporation Information
Table 158. Huaren Pharmaceutical Description and Major Businesses
Table 159. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Huaren Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Huaren Pharmaceutical Recent Developments
Table 162. Jubilant Pharma Corporation Information
Table 163. Jubilant Pharma Description and Major Businesses
Table 164. Jubilant Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Jubilant Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Jubilant Pharma Recent Developments
Table 167. Amneal Pharmaceuticals Corporation Information
Table 168. Amneal Pharmaceuticals Description and Major Businesses
Table 169. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Amneal Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Amneal Pharmaceuticals Recent Developments
Table 172. Zhejiang Huahai Pharmaceutical Corporation Information
Table 173. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 174. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Zhejiang Huahai Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Zhejiang Huahai Pharmaceutical Recent Developments
Table 177. Square Pharmaceuticals Corporation Information
Table 178. Square Pharmaceuticals Description and Major Businesses
Table 179. Square Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Square Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Square Pharmaceuticals Recent Developments
Table 182. Unichem Laboratories Corporation Information
Table 183. Unichem Laboratories Description and Major Businesses
Table 184. Unichem Laboratories Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. Unichem Laboratories Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Unichem Laboratories Recent Developments
Table 187. LG Life Sciences Corporation Information
Table 188. LG Life Sciences Description and Major Businesses
Table 189. LG Life Sciences Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. LG Life Sciences Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. LG Life Sciences Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Valsartan Distributors List
Table 195. Valsartan Customers List
Table 196. Valsartan Market Trends
Table 197. Valsartan Market Drivers
Table 198. Valsartan Market Challenges
Table 199. Valsartan Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan Product Picture
Figure 3. Global Valsartan Market Share by Type in 2021 & 2028
Figure 3. 40 mg Tablets Product Picture
Figure 4. 80 mg Tablets Product Picture
Figure 5. 160 mg Tablets Product Picture
Figure 6. 320 mg Tablets Product Picture
Figure 7. Global Valsartan Market Share by Application in 2021 & 2028
Figure 8. Hypertension
Figure 9. Heart Failure
Figure 10. Heart Attack
Figure 11. Valsartan Report Years Considered
Figure 12. Global Valsartan Sales 2017-2028 (K Units)
Figure 13. Global Valsartan Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Valsartan Revenue 2017-2028 (US$ Million)
Figure 15. Global Valsartan Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Valsartan Sales Market Share by Region (2017-2022)
Figure 17. Global Valsartan Sales Market Share by Region (2023-2028)
Figure 18. North America Valsartan Sales YoY (2017-2028) & (K Units)
Figure 19. North America Valsartan Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Valsartan Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Valsartan Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Valsartan Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Valsartan Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Valsartan Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Valsartan Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Valsartan Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Valsartan Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Valsartan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Valsartan in the World: Market Share by Valsartan Revenue in 2021
Figure 30. Global Valsartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Valsartan Sales Market Share by Type (2017-2028)
Figure 32. Global Valsartan Revenue Market Share by Type (2017-2028)
Figure 33. Global Valsartan Sales Market Share by Application (2017-2028)
Figure 34. Global Valsartan Revenue Market Share by Application (2017-2028)
Figure 35. North America Valsartan Sales Market Share by Type (2017-2028)
Figure 36. North America Valsartan Revenue Market Share by Type (2017-2028)
Figure 37. North America Valsartan Sales Market Share by Application (2017-2028)
Figure 38. North America Valsartan Revenue Market Share by Application (2017-2028)
Figure 39. North America Valsartan Sales Share by Country (2017-2028)
Figure 40. North America Valsartan Revenue Share by Country (2017-2028)
Figure 41. United States Valsartan Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Valsartan Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Valsartan Sales Market Share by Type (2017-2028)
Figure 44. Europe Valsartan Revenue Market Share by Type (2017-2028)
Figure 45. Europe Valsartan Sales Market Share by Application (2017-2028)
Figure 46. Europe Valsartan Revenue Market Share by Application (2017-2028)
Figure 47. Europe Valsartan Sales Share by Country (2017-2028)
Figure 48. Europe Valsartan Revenue Share by Country (2017-2028)
Figure 49. Germany Valsartan Revenue (2017-2028) & (US$ Million)
Figure 50. France Valsartan Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Valsartan Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Valsartan Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Valsartan Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Valsartan Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Valsartan Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Valsartan Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Valsartan Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Valsartan Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Valsartan Revenue Share by Region (2017-2028)
Figure 60. China Valsartan Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Valsartan Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Valsartan Revenue (2017-2028) & (US$ Million)
Figure 63. India Valsartan Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Valsartan Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Valsartan Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Valsartan Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Valsartan Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Valsartan Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Valsartan Sales Market Share by Type (2017-2028)
Figure 70. Latin America Valsartan Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Valsartan Sales Market Share by Application (2017-2028)
Figure 72. Latin America Valsartan Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Valsartan Sales Share by Country (2017-2028)
Figure 74. Latin America Valsartan Revenue Share by Country (2017-2028)
Figure 75. Mexico Valsartan Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Valsartan Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Valsartan Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Valsartan Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Valsartan Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Valsartan Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Valsartan Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Valsartan Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Valsartan Revenue Share by Country (2017-2028)
Figure 84. Turkey Valsartan Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Valsartan Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Valsartan Revenue (2017-2028) & (US$ Million)
Figure 87. Valsartan Value Chain
Figure 88. Valsartan Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis Sun Pharmaceutical Teva Mylan Alembic Pharmaceuticals Lupin Aurobindo Pharma Macleods Pharmaceuticals HETERO Torrent Pharmaceuticals Huaren Pharmaceutical Jubilant Pharma Amneal Pharmaceuticals Zhejiang Huahai Pharmaceutical Square Pharmaceuticals Unichem Laboratories LG Life Sciences